Terms: = Colorectal cancer AND ATM, TELO1, 472, ENSG00000149311, TEL1, ATD, ATE, DKFZp781A0353, AT1, Q13315, MGC74674, ATDC, ATC, ATA AND Diagnosis
66 results:
1. Type 2 diabetes mellitus and post-colonoscopy colorectal cancer: clinical and molecular characteristics and survival.
Boysen ML; Troelsen FS; Sørensen HT; Erichsen R
Cancer Causes Control; 2024 Jul; 35(7):1043-1052. PubMed ID: 38483686
[TBL] [Abstract] [Full Text] [Related]
2. Integrated bioinformatics approach to unwind key genes and pathways involved in colorectal cancer.
Mobeen SA; Saxena P; Jain AK; Deval R; Riazunnisa K; Pradhan D
J Cancer Res Ther; 2023 Oct; 19(7):1766-1774. PubMed ID: 38376276
[TBL] [Abstract] [Full Text] [Related]
3. Rate of Pathogenic Germline Variants in Patients With Lung cancer.
Sorscher S; LoPiccolo J; Heald B; Chen E; Bristow SL; Michalski ST; Nielsen SM; Lacoste A; Keyder E; Lee H; Nussbaum RL; Martins R; Esplin ED
JCO Precis Oncol; 2023 Sep; 7():e2300190. PubMed ID: 37992258
[TBL] [Abstract] [Full Text] [Related]
4. Whole exome germline sequencing in early-onset prostate cancer patients: Genomic findings and clinical outcomes.
Siegelmann-Danieli N; Neiman V; Bareket-Samish A; Berger R; Peretz A; Alapi H; Tsur E; Patalon T; Beller D; Rimler G; Chodick G; Shohat M
Prostate; 2024 Jan; 84(1):39-46. PubMed ID: 37842866
[TBL] [Abstract] [Full Text] [Related]
5. Trends in pathology diagnoses during 10 years of a colorectal cancer screening programme.
Carragher R; Ings GR; Baker G; Rosborough J; Johnston DB; Shah R; Cameron I; O'Neill C; Kelly PJ; McVeigh G; Irwin S; Khosraviani K; Dickey W; Owen TA; McKee CF; Coleman HG; Loughrey MB
Histopathology; 2023 Nov; 83(5):756-770. PubMed ID: 37565291
[TBL] [Abstract] [Full Text] [Related]
6. Role of miR-21 in the diagnosis of colorectal cancer: Meta-analysis and bioinformatics.
Li J; Chen H; Sun G; Zhang X; Ye H; Wang P
Pathol Res Pract; 2023 Aug; 248():154670. PubMed ID: 37418993
[TBL] [Abstract] [Full Text] [Related]
7. Educational differences in healthcare use among survivors after breast, prostate, lung, and colon cancer - a SEQUEL cohort study.
Levinsen AKG; Kjaer TK; Maltesen T; Jakobsen E; Gögenur I; Borre M; Christiansen P; Zachariae R; Laurberg S; Christensen P; Kroman N; Larsen SB; Degett TH; Hölmich LR; Brown PN; Johansen C; Kjær SK; Thygesen LC; Dalton SO
BMC Health Serv Res; 2023 Jun; 23(1):674. PubMed ID: 37349718
[TBL] [Abstract] [Full Text] [Related]
8. Fistula-Associated Anal Adenocarcinoma: A 20-Year Single-Center Experience.
Harpain F; Dawoud C; Wimmer K; Schlager L; Kirchnawy S; Rizk D; Girgis K; Mittermair E; Oberndorfer F; Wöran K; Riss S; Stift A; Stift J
Ann Surg Oncol; 2023 Jun; 30(6):3517-3527. PubMed ID: 36757514
[TBL] [Abstract] [Full Text] [Related]
9. Identification of novel characteristic biomarkers and immune infiltration profile for the anaplastic thyroid cancer via machine learning algorithms.
Li C; Dong X; Yuan Q; Xu G; Di Z; Yang Y; Hou J; Zheng L; Chen W; Wu G
J Endocrinol Invest; 2023 Aug; 46(8):1633-1650. PubMed ID: 36725810
[TBL] [Abstract] [Full Text] [Related]
10. Socioeconomic inequalities in prevalence, awareness, treatment and control of hypertension: evidence from the PERSIAN cohort study.
Amini M; Moradinazar M; Rajati F; Soofi M; Sepanlou SG; Poustchi H; Eghtesad S; Moosazadeh M; Harooni J; Aghazadeh-Attari J; Fallahi M; Fattahi MR; Ansari-Moghaddam A; Moradpour F; Nejatizadeh A; Shahmoradi M; Mansour-Ghanaei F; Ostadrahimi A; Ahmadi A; Khaledifar A; Saghi MH; Saki N; Mohebbi I; Homayounfar R; Farjam M; Nadimi AE; Kahnooji M; Pourfarzi F; Zamani B; Rezaianzadeh A; Johari MG; Mirzaei M; Dehghani A; Motlagh SFZ; Rahimi Z; Malekzadeh R; Najafi F
BMC Public Health; 2022 Jul; 22(1):1401. PubMed ID: 35864469
[TBL] [Abstract] [Full Text] [Related]
11. cancer Risk C (CR-C), a functional genomics test is a sensitive and rapid test for germline mismatch repair deficiency.
Alim I; Loke J; Yam S; Templeton AS; Newcomb P; Lindor NM; Pai RK; Jenkins MA; Buchanan DD; Gallinger S; Klugman S; Ostrer H
Genet Med; 2022 Sep; 24(9):1821-1830. PubMed ID: 35616648
[TBL] [Abstract] [Full Text] [Related]
12. Circulating Clusterin Levels and cancer Risk: A Systematic Review and Meta-Analysis.
Beheshti Namdar A; Kabiri M; Mosanan Mozaffari H; Aminifar E; Mehrad-Majd H
Cancer Control; 2022; 29():10732748211038437. PubMed ID: 35465749
[TBL] [Abstract] [Full Text] [Related]
13. The prognostic value of extramural venous invasion in preoperative MRI of rectal cancer patients.
Lehtonen TM; Koskenvuo LE; Seppälä TT; Lepistö AH
Colorectal Dis; 2022 Jun; 24(6):737-746. PubMed ID: 35218137
[TBL] [Abstract] [Full Text] [Related]
14. Diagnostic usefulness of selected proteases and acute phase factors in patients with colorectal adenocarcinoma.
Sebzda T; Gnus J; Dziadkowiec B; Latka M; Gburek J
World J Gastroenterol; 2021 Oct; 27(39):6673-6688. PubMed ID: 34754160
[TBL] [Abstract] [Full Text] [Related]
15. Being assigned a clinical nurse specialist is associated with better experiences of cancer care: English population-based study using the linked National cancer Patient Experience Survey and cancer Registration Dataset.
Alessy SA; Lüchtenborg M; Rawlinson J; Baker M; Davies EA
Eur J Cancer Care (Engl); 2021 Nov; 30(6):e13490. PubMed ID: 34309952
[TBL] [Abstract] [Full Text] [Related]
16. Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis.
Zhuang Y; Wang H; Jiang D; Li Y; Feng L; Tian C; Pu M; Wang X; Zhang J; Hu Y; Liu P
BMC Cancer; 2021 Apr; 21(1):380. PubMed ID: 33836681
[TBL] [Abstract] [Full Text] [Related]
17. Underwater endoscopic mucosal resection versus endoscopic submucosal dissection for 20-30 mm colorectal polyps.
Inoue T; Nakagawa K; Yamasaki Y; Shichijo S; Kanesaka T; Maekawa A; Higashino K; Uedo N; Ishihara R; Takeuchi Y
J Gastroenterol Hepatol; 2021 Sep; 36(9):2549-2557. PubMed ID: 33724540
[TBL] [Abstract] [Full Text] [Related]
18. Incidence and Risk of Various Types of Arterial Thromboembolism in Patients With cancer.
Wang J; Kim YD; Kim CH
Mayo Clin Proc; 2021 Mar; 96(3):592-600. PubMed ID: 33673912
[TBL] [Abstract] [Full Text] [Related]
19. Co-occurrence of germline pathogenic variants for different hereditary cancer syndromes in patients with Lynch syndrome.
Ferrer-Avargues R; Castillejo MI; Dámaso E; Díez-Obrero V; Garrigos N; Molina T; Codoñer-Alejos A; Segura Á; Sánchez-Heras AB; Castillejo A; Soto JL
Cancer Commun (Lond); 2021 Mar; 41(3):218-228. PubMed ID: 33630411
[TBL] [Abstract] [Full Text] [Related]
20. Predicted Chemotherapy Benefit for Breast cancer Patients With Germline Pathogenic Variants in cancer Susceptibility Genes.
Kurian AW; Ward KC; Abrahamse P; Hamilton AS; Katz SJ
JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 33426465
[TBL] [Abstract] [Full Text] [Related]
[Next]
